九洲药业 (603456.sh)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(九洲药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年一季报2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 1,475,743,576.445,523,418,175.434,576,609,415.433,254,642,522.091,751,242,194.315,445,105,154.774,372,695,484.552,954,488,046.321,373,675,379.24
 营业利润(元) 280,086,558.721,175,771,384.981,085,851,455.66714,949,160.50349,452,953.251,107,911,627.66873,921,630.43555,808,705.68253,540,462.07
 利润总额(元) 280,042,041.461,180,642,037.571,088,016,968.01717,732,565.52349,478,460.471,103,821,675.80871,579,890.61553,947,429.80251,865,967.35
 净利润(元) 236,172,887.541,031,371,775.69964,436,582.77621,320,792.40279,457,100.43920,550,114.25741,479,246.24468,130,098.23207,376,991.20
 归属于母公司股东的净利润(元) 236,758,875.391,033,255,687.14966,770,643.95621,727,529.68280,694,039.23920,922,206.88743,228,827.92468,062,251.01207,810,018.06
盈利能力:
 销售毛利率(%) 34.0437.6639.3138.4036.9034.6634.7235.1335.36
 销售净利率(%) 16.0018.6721.0719.0915.9616.9116.9615.8415.10
 净资产收益率(%) 2.8315.0214.299.654.37----
 总资产报酬率ROA(%) 2.2511.7810.787.123.86----
 投入资本回报率ROIC(%) 2.4013.6012.257.873.7015.7712.647.843.54
营运能力:
 存货周转率(次) 0.541.731.521.150.63----
 应收账款周转率(次) 1.226.765.283.342.31----
 总资产周转率(次) 0.130.590.480.340.19----
偿债能力:
 资产负债率(%) 28.6921.3724.9928.4825.7432.1233.5937.7736.38
 股东权益比率(%) 70.7377.9774.3770.8673.5866.9365.4161.2263.50
 已获利息倍数(倍) -13.83-14.61-18.24-21.7245.33-11.81-8.37-8.8621.12
 流动比率 2.713.813.172.612.861.801.931.721.77
 速动比率 2.062.612.321.932.090.871.061.051.02
发展能力:
 营业收入增长率(%) -15.731.444.6610.1627.4934.0145.5558.1560.46
 营业利润增长率(%) -19.856.1324.2528.6337.8347.0159.1468.81123.59
 税后利润增长率(%) -15.6512.1730.0832.8335.0745.2857.0970.31120.13
 净资产增长率(%) 7.4959.7463.7865.4968.2215.7216.6415.8314.90
 总资产增长率(%) 11.8237.1344.0642.9845.1812.4021.5028.5132.72

前瞻产业研究院